Starpharma EPS
Was ist das EPS von Starpharma?
EPS von Starpharma Holdings Limited ist 0.00
Was ist die Definition von EPS?
Der Gewinn pro Aktie (EPS) ist der Anteil des Gewinns eines Unternehmens, der jeder im Umlauf befindlichen Stammaktie zugewiesen wird. Es wird der Verdünnung angepasst und über letzten zwölf Monate nachgerechnet.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS von Unternehmen in Health Care Sektor auf ASX im Vergleich zu Starpharma
Was macht Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Unternehmen mit eps ähnlich Starpharma
- MEIGU Technology hat EPS von 0.00
- Jiu Rong hat EPS von 0.00
- Nyrada hat EPS von 0.00
- Extrawell Pharmaceutical hat EPS von 0.00
- NexgenRx hat EPS von 0.00
- Freeform Capital Partners hat EPS von 0.00
- Starpharma hat EPS von 0.00
- Bounty Oil & Gas NL hat EPS von 0.00
- Quest Water Global hat EPS von 0.00
- Marley Spoon AG hat EPS von 0.00
- Torian Resources hat EPS von 0.00
- Duiba hat EPS von 0.00
- Daisho Microline hat EPS von 0.00